Share This Article:

Impact of Chagas Disease on Human Evolution: The Challenges Continue

Full-Text HTML Download Download as PDF (Size:70KB) PP. 1-6
DOI: 10.4236/aa.2013.34A001    4,424 Downloads   8,354 Views  

ABSTRACT

Chagas disease affects 8 to 10 million people worldwide and, although most of them live in Latin America, there has been an increase in cases occurring in countries of Europe and North America although most of them live in Latin America. This study aims to describe the epidemiological situation in the present as well as government and research centers actions, particularly the study group of Chagas disease of the School of Medicine of Botucatu (FMB/UNESP)/Brazil.

Cite this paper

Navarro, E. & Pereira, P. (2013). Impact of Chagas Disease on Human Evolution: The Challenges Continue. Advances in Anthropology, 3, 1-6. doi: 10.4236/aa.2013.34A001.

References

[1] Araújo, A., Jansen, A. A., Reinhard, K., & Ferreira, L. F. (2009). Paleoparasitology of Chagas disease—A review. Memórias do Instituto Osvaldo Cruz, 104, 9-16.
http://dx.doi.org/10.1590/S0074-02762009000900004
[2] Aufderhreide, A. C., Salo, W., Madden, M., Streiz, J., Buikstra, J., Guhl, F. et al. (2004). A 9000-year record of Chagas’ disease. PNAS, 101, 2034-2039.
[3] Bern, C., & Montgomery, S. P. (2009). An estimate of the burden of Chagas diseases inthe United States. Clinical Infectious Diseases, 49, 52-54. http://dx.doi.org/10.1086/605091
[4] Brito, C. R. N., Sampaio, G. H. F., Camara, A. C. J., Nunes, D. F., Azevedo, P. R. M., Chiari, E. et al. (2012). Seroepidemiology of Trypanosoma cruzi infection in the semiarid rural zone of the State of Rio Grande do Norte, Brazil. Revista da Sociedade de Medicina Tropica, 5, 346-352.
http://dx.doi.org/10.1590/S0037-86822012000300013
[5] Carvalho, M. E., Silva, R. A., Wanderley, D. M. V., & Barata, J. M. S. (2011). Programa de controle da doenca de Chagas no Estado de Sao Paulo: Aspectos soroepidemiológicos em microrregioes geográficas homogêneas. Revista da Sociedade Brasileira de Medicina Tropical, 44, 95-106.
[6] Chagas, C. (2008). A new diseaseentity in man: A report onetiologic and clinical observations. International Journal of Epidemiology, 37, 694-695.
[7] Flores-Chavez, M. D., Merino, F. J., García-Bujalance, S., Martin-Rabadán, P., Merino, P., García-Bermejo, I. et al. (2011). Surveillance of Chagas disease in pregnant women in Madrid, Spain, from 2008 to 2010. Eurosurveillance, 16, 1-7.
[8] Combs, T. P., Nagajyothi, Mukherjee, S., Almeida, C. J. G., Jelicks, L. A., Schubert, W. et al. (2005). The adipocyte as an important target cell for Trypanosoma cruzi infection. The Journal of Biological Chemistry, 280, 24085-24094.
http://dx.doi.org/10.1074/jbc.M412802200
[9] Coura, J. R., & Borges-Pereira, J. (2011). Chronic phase of Chagas disease: Why should it be treated? A comprehensivereview. Memórias do Instituto Oswaldo Cruz, 106, 641-645.
[10] Coura, J. R. (2007). Origem, determinantes e morbidade da doenca de chagas. Revista de la Facultad de Ciencias de laSalud, 11, 62-66.
[11] Coura, J. R. (1997). Síntese histórica e evolucao dos conhecimentos sobre a doenca de chagas. In Clínica e terapêutica da doenca de Chagas: Uma abordagem prática para o clínico geral (486 p). Editora FIOCRUZ, Rio de Janeiro.
http://books.scielo.org
[12] Dias, J. C. P., Neto, V. A., & Luna, E. J. A. (2011). Mecanismos alternativos de transmissao do Trypanosoma cruzi no Brasil e sugestoes para sua prevencao. Revista da Sociedade Brasileira de Medicina Tropical, 44, 375-379.
http://dx.doi.org/10.1590/S0037-86822011005000032
[13] Dias, J. C. P. (2006). Doenca de Chagas e transfusao de sangue no Brasil: Vigilancia e desafios. Revista Brasileira de Hematologia, 28, 83-84.
[14] Fernandes, A., Iniguez, A. M., Lima, V. S., Souza, S. M. F. M., Ferreira, L. F., Vicente, A. C. P., & Jansen, A. M. (2008). Pre-Columbian Chagas disease in Brazil: Trypanosoma cruzi I in the archaeological remains of a human in Peruacu Valley, Minas Gerais, Brazil. Memórias do Instituto Oswaldo Cruz, 103, 514-516.
http://dx.doi.org/10.1590/S0074-02762008000500021
[15] Ferreira, A. V. M., Segatto, M., Menezes, Z., Macedo, A. M., Gelape, C., Andrade, L. O. et al. (2011). Evidence for Trypanosoma cruzi in adipose tissue in human chronic Chagas disease. Microbes and Infection, 13, 1002-1005.
http://dx.doi.org/10.1016/j.micinf.2011.06.002
[16] Fitarelli, D. B., & Horn, J. F. (2009). Descarte de bolsas de sangue devido à reatividade para doenca de Chagas em um laboratório de triagem sorológica de doadores em Porto Alegre-RS. Revista Brasileira de Hematologia, 31, 310-314.
http://dx.doi.org/10.1590/S1516-84842009005000066
[17] Flores-Chaves, M. D., Merino, F. J., Bujalance, S. G., Martin-Rabadán, P., Merino, P., Gárcia-Bermejo I. et al. (2011). Surveillance of Chagas disease in pregnant women in Madrid, Spain, from 2008 to 2010. Eurosurveillance, 16, 1-6.
http://www.eurosurveillance.org
[18] Geraix, J., Ardisson, L. P., Marcondes-Machado, J., & Pereira, P. C. M. (2007). Clinical and nutritional profile of individuals with Chagas disease. The Brazilian Journal of Infectious Diseases, 11, 411-414.
http://dx.doi.org/10.1590/S1413-86702007000400008
[19] Goldbaum, M., & Barreto, M. L. (2008). Commentary: The contribution and example of Carlos Chagas. International Journal of Epidemiology, 37, 697-698.
[20] Kropf, S. P. (2013). Carlos Chagas: Infancia, primeiros estudos e formacao médica.
http://www.fiocruz.br/chagas/cgi/cgilua.exe/sys/start.htm?sid=1
[21] Lescure, F. X., Loup, G. L., Freilij, H., Develoux, M., Paris, L., Brutus, L. et al. (2010). Chagas disease: Changes in knowledge and management. Lancet Infection Disease, 10, 556-570.
http://dx.doi.org/10.1016/S1473-3099(10)70098-0
[22] Lucheis, S. B., Silva, A. V., Araújo Jr., J. P., Langoni, H., Meira, D. A., & Marcondes-Machado, J. (2005). Trypanosomatids in dogs belonging to individuals with chronic Chagas’ disease living in Botucatu town and surrounding region, Sao Paulo State, Brazil. The Journal of Venomous Animals and Toxins including Tropical Diseases, 11, 492-509. http://dx.doi.org/10.1590/S1678-91992005000400009
[23] Moraes-Souza, H., & Ferreira-Silva, M. M. (2011). O controle da transmissao transfusional. Revista da Sociedade Brasileira de Medicina Tropical, 44, 64-67.
[24] Moncayo, A., & Silveira, A. C. (2009). Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Memórias do Instituto Oswaldo Cruz, 104, 17-30.
[25] Nagajyothi, F., Machado, F. S., Burleigh, B. A., Jelicks, L. A., Scherer, P. E., Mukherjee, S. et al. (2012). Mechanisms of Trypanosoma cruzi persistence in Chagas disease. Cellular Microbiology, 14, 634-643.
http://dx.doi.org/10.1111/j.1462-5822.2012.01764.x
[26] Nagajyothi, F., Desruisseaux, M. S., Weiss, L. M., Chua, S., Albanese, C., Machado, F. S. et al. (2009). Chagas disease, adipose tissue and the metabolic syndrome. Memórias do Instituto Oswaldo Cruz, 104, 2019-2225.
[27] Navarro, E. C., Abreu, M. M., Tavares, F. C., Corrente, J. E., Arruda, C. M., & Pereira, P. C. M. (2013b). Indeterminate form of Chagas’ disease and metabolic syndrome: A dangerous combination. American Journal of Medicine and Medical Science, 3, 68-73.
[28] Navarro, E. C., Pereira, P. C. M., Goto, R. L., Ricaboni, I., Henriques, R. M. S., Neves, S. L., Xanini, J. M., & Dorini, A. A. (2013a). Seroprevalence of chagasic infection in young individuals in a blood center in the State of Sao Paulo, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 55, 245-250.
http://dx.doi.org/10.1590/S0036-46652013000400005
[29] Navarro, M., Navaza, B., Guionnet, A., & López-Vélez, R. (2012). Chagas disease in Spain: Need for further public health measures. PLOS Neglected Tropical Diseases, 12, 1-4.
http://dx.doi.org/10.1371/journal.pntd.0001962
[30] Nóbrega, A. A., Garcia, M. H., Tatto, E., Obara, M. T., Costa, E., Sobel, J. et al. (2009). Oral transmission of Chagas disease by consumption of Acaí palm fruit, Brazil. Emerging Infectious Diseases, 15, 653-655. http://dx.doi.org/10.3201/eid1504.081450
[31] Ostermayer, A. L., Passos, A. D. C., Silveira, A. C., Ferreira, A. W., Macedo, V., & Prata, A. R. (2011). The national survey of seroprevalence for evaluation of the control of Chagas disease in Brazil (2001-2008). Revista da Sociedade Brasileira de Medicina Tropical, 44, 108-121.
[32] Pan American Health Organization (2012). Notas descriptivas— Enfermedad de Chagas.
http://new.paho.org/hq/index.php?option=com_content&view=article&id=5856&Itemid=4196
[33] Petherick, A. (2010). Country by country. Nature, 465, S10-S11.
http://dx.doi.org/10.1038/nature09223
[34] Picka, M. C. M., Meira, D. A., Carvalho, T. B., Peresi, E., & Marcondes-Machado, J. (2007). Definition of a diagnostic routine in individuals with inconclusive serology for Chagas disease. The Brazilian Journal of Infectious Diseases, 11, 226-233.
http://dx.doi.org/10.1590/S1413-86702007000200012
[35] Rassi Jr., A., Rassi, A., & Marin-Neto, J. A. (2010). Chagas disease. Lancet, 375, 1388-1402.
http://dx.doi.org/10.1016/S0140-6736(10)60061-X
[36] Rey, L. (2011). Parasitologia (4 ed.). Rio de Janeiro: Guanabara Koogan.
[37] Rissio, A. M., Riarte, A. R., Garcia, M. M., Esteva, M. I., Quaglino, M., & Ruiz, A. M. (2010). Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in na urban reference health Center in a nonendemic area of Argentina. The American Journal of Tropical Medicine and Hygiene, 82, 838-845.
http://dx.doi.org/10.4269/ajtmh.2010.08-0383
[38] Romero, M., Postigo, J., Schneider, D., Chippaux, J. P., Santalla, J. A., & Brutus, L. (2011). Door-to-door screening as a strategy for the detection of congenital chagas disease in rural Bolívia. Tropical Medicine and International Health, 16, 562-569.
http://dx.doi.org/10.1111/j.1365-3156.2011.02746.x
[39] Schapachnik, E., Riera, A. R. P., Dubner, S., Filho, C. F., Uchida, A. H., & Ferreira, C. (2009). Dr. Carlos justiniano ribeiro das chagas (1879-1934): A giant of the Third World. Cardiology Journal, 16, 592-593.
[40] Sathler-Avelar, R., Vitelli-Avelar, D., Teixeira-Carvalho, A., Martins-Filho, O. A. (2009). Innate immunity and regulatory T-cells in human chagas disease: What must be understood? Memórias do Instituto Oswaldo Cruz, 104, 246-251.
http://dx.doi.org/10.1590/S0074-02762009000900031
[41] Silveira, A. C., & Junior, F. P. (2011). A insercao institucional do controle da doenca de chagas. Revista da Sociedade Brasileira de Medicina Tropical, 44, 19-24.
http://dx.doi.org/10.1590/S0037-86822011000800004
[42] Soares, L. M. B. (2009). Eliminacao da transmissao e morbidade da infeccao chagásica cronica em pacientes autóctones da microrregiao do rio negro, Estado do Amazonas (1997-2008). Dissertacao. Rio de Janeiro: Instituto Osvaldo Cruz.
[43] Tanowitz, H. B., Julicks, L. A., Machado, F. S., Esper, L., Qi, X., Deruisseaux, M. S., et al. (2011). Adipose tissue, diabetes and chagas disease. Advances in Parasitology, 76, 235-250.
http://dx.doi.org/10.1016/B978-0-12-385895-5.00010-4
[44] Zingales, B. (2011). Trypanosoma cruzi: One parasite, two parasites or several parasites of chagas disease? Revista da Biologia,6b, 44-48. http://dx.doi.org/10.7594/revbio.6b.09

  
comments powered by Disqus

Copyright © 2017 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.